María
Currás Freixes
Investigadora ata 2022
University Hospital of Zurich
Zúrich, SuizaPublicacións en colaboración con investigadores/as de University Hospital of Zurich (5)
2023
-
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
Nature Communications, Vol. 14, Núm. 1
2021
2019
-
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma
Theranostics, Vol. 9, Núm. 17, pp. 4946-4958
-
Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-PronO study): A European network for the study of adrenal tumors retrospective study
Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 6, pp. 2367-2374
2018
-
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients
Genetics in Medicine, Vol. 20, Núm. 12, pp. 1652-1662